Skip to main content

Table 1 Data to be collected

From: Postoperative glucocorticoids in patients with acute type A aortic dissection (GLAD): study protocol for a prospective, single-center, randomized controlled trial

Time Points

Day of ICU admission

Treatment

Preoperative

Pre-drug

24 h

48 h

72 h

Discharge or death

Enrollment

x

      

 Informed consent

x

      

 Inclusion and exclusion criteria

x

      

 Demographicsa

x

      

 Past medical historyb

x

      

 Pre-operative cardiac functionc

x

      

 Operative informationd

x

      

Assessment

 Temperature

 

x

x

x

x

x

 

 Respiratory rate

 

x

x

x

x

x

 

 Heart rate

 

x

x

x

x

x

 

 Systolic blood pressure

 

x

x

x

x

x

 

 Diastolic blood pressure

 

x

x

x

x

x

 

 SOFA score

x

  

x

x

x

 

 Methylprednisolone administration

   

x

x

x

 

 Inflammatory indicatorse

 

x

x

x

x

x

 

 Blood countf

 

x

x

x

x

x

 

 Blood biochemistryg

 

x

x

x

x

x

 

 Arterial blood gash

 

x

x

x

x

x

 

 Concomitant medicationsi

 

x

x

x

x

x

 

 Adverse eventsj

   

x

x

x

x

 24 h fluid intake and output

 

x

x

x

x

x

 
  1. TIA Transient ischemic attack, COPD Chronic obstructive pulmonary disease, DM Diabetes mellitus, NYHA New York Heart Association, LVEF Left ventricular ejection fractions, TAPSE Tricuspid annular plane systolic excusion, ECG Electrocardiogram, ALICE Albumin-indocyanine green evaluation, ICU Intensive care unit, CCB Calcium channel blockers, CRP C-reactive protein, PCT Procalcitonin, ESR Erythrocyte sedimentation rate, TNFα Tumor necrosis factor-α, IL-6 Interleukin-6, IL-10 Interleukin-10, pH potential of Hydrogen, CRRT Continuous renal replacement therapy
  2. aage, sex, height(cm), weight(kg), smoking and alcohol consumption
  3. bpre-existing definite preoperative diagnosis; previous or screening period medical history (including at least hypertension, TIA, COPD, stroke, DM, various arrhythmias, peptic ulcer)
  4. cpreoperative NYHA classification, preoperative cardiac ultrasound including LVEF, TAPSE, preoperative ECG, myocardial enzyme profile, preoperative ALICE score for entrapment
  5. dname of the procedure, duration of the procedure (min), time outside the body (min), time of block (min), time of transfer to the ICU. Intraoperative dose and time of hormone use, blood loss, and transfusion volume; β-blockers, CCB, anticoagulants such as aspirin, antiplatelet agents, antihypertensive agents, cardiotonic agents, proton pump inhibitors or H2-blockers, antibiotics used within the previous 7 days
  6. eCRP, PCT, ESR, TNFα, IL-6, IL-10
  7. fhemoglobin, white blood cell, neutrophil count, lymphocyte count, platelet count
  8. galanine aminotransferase, aspartate aminotransferase, total bilirubin, direct bilirubin, serum creatinine, plasma brain natriuretic peptide precursor, serum troponin T
  9. hpH, partial pressure of oxygen, partial pressure of carbon dioxide, electrolytes (potassium ion, sodium ion), blood glucose
  10. iβ-blockers, CCB, anticoagulants such as aspirin, antiplatelet agents, antihypertensive drugs, cardiotonic drugs
  11. joccurrence of various infections, CRRT, cerebrovascular events, gastrointestinal bleeding or perforation, cardiogenic shock, etc
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us